Detalles de la búsqueda
1.
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Lancet Oncol
; 16(5): 499-508, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25877855
2.
Immune checkpoint inhibitor-induced myocarditis, myositis, myasthenia gravis and transaminitis: a case series and review.
Immunotherapy
; 14(7): 511-520, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35321560
3.
Clinical and molecular profile of young adults with early-onset colorectal cancer: Experience from four Australian tertiary centers.
Asia Pac J Clin Oncol
; 18(6): 660-668, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35098672
4.
A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma.
Cancer
; 117(20): 4732-9, 2011 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21456002
5.
Preclinical evaluation of novel, all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profiles.
Anticancer Drugs
; 22(1): 24-34, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20881836
6.
A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy.
Mol Cancer
; 9: 69, 2010 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-20350333
7.
Development and assessment of novel all-in-one parenteral formulations with integrated anticoagulant properties for the concomitant delivery of 5-fluorouracil and calcium folinate.
Anticancer Drugs
; 20(9): 822-31, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19606016
8.
First-in-human phase I study of infusional and bolus schedules of Deflexifol, a novel 5-fluorouracil and leucovorin formulation, after failure of standard treatment.
Asia Pac J Clin Oncol
; 15(3): 151-157, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30843362
9.
Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial.
Cancer Chemother Pharmacol
; 80(3): 599-608, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28744667
10.
Comparative effectiveness of 5-fluorouracil with and without oxaliplatin in the treatment of colorectal cancer in clinical practice.
Anticancer Res
; 33(3): 1053-60, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23482781
11.
Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial.
Cancer Chemother Pharmacol
; 67(1): 153-63, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20333384
Resultados
1 -
11
de 11
1
Próxima >
>>